Comparative Evaluation of Efficacy of Clindamycin and Trimethoprim - Sulfamethoxazole for Treating Patients with Uncomplicated Skin Infections
Background: The most common bacterial causes of skin and soft tissue infections (SSTI) are group A Streptococcus (GAS) and Staphylococcus aureus, the key bacterial agents of impetigo, cellulitis, abscesses, and wound infections. Aim of the study: To compare efficiency of clindamycin and trimethoprim-sulfamethoxazole for treating patients with uncomplicated skin infections. Materials & Methods: The study was conducted in the department of general medicine of the Government S.K. Hospital, Sikar, Rajasthan, India. . For the study we selected subjects from the surgical ward of the hospital of the medical institute. The patients diagnosed with uncomplicated skin infection were included in the study. A total of 42 patients were selected for the study.
Results: A total of 42 patients were enrolled, 21 in group 1 and 21 in group 2. We observed that clinical cure at 17-20 days was 78.03 % in Group 1 and 74.31 % in group 2. Clinical cure at one month follow up was 71.22% in group 1 and 65.21% in group 2. Clinical cure in adults in group 1 was 76.2% and in group 2 was 74.84%. Clinical cure in pediatrics was 83.29% in group 1 and 79.35% in group 2. Clinical cure rate of abscess for group 1 was 77.96% and for group 2 was 81.21%. Conclusion: Within the limitations of the study we conclude that both the drug combinations i.e., clindamycin and trimethoprim-sulfamethoxazole are equally effective in treating uncomplicated skin infections.
2. Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA., Jr Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008;51:291–8.
3. Edelsberg J, Taneja C, Zervos M, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis. 2009;15:1516–8.
4. Carratalà J, Rosón B, Fernández-Sabé N, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis. 2003;22:151–7.
5. Lipsky BA, Kollef MH, Miller LG, Sun X, Johannes RS, Tabak YP. Predicting bacteremia among patients hospitalized for skin and skin-structure infections: derivation and validation of a risk score. Infect Control Hosp Epidemiol. 2010;31:828–37.
6. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–74.
7. Miller LG, Daum RS, Creech CB, et al. Clindamycin versus Trimethoprim–Sulfamethoxazole for Uncomplicated Skin Infections. The New England journal of medicine. 2015;372(12):1093-1103. doi:10.1056/NEJMoa1403789.
8. LaPlante KL, Leonard SN, Andes DR, Craig WA, Rybak MJ. Activities of Clindamycin, Daptomycin, Doxycycline, Linezolid, Trimethoprim-Sulfamethoxazole, and Vancomycin against Community-Associated Methicillin-Resistant Staphylococcus aureus with Inducible Clindamycin Resistance in Murine Thigh Infection and In Vitro Pharmacodynamics Models. Antimicrobial Agents and Chemotherapy. 2008;52(6):2156-2162. doi:10.1128/AAC.01046-07.
9. Hersh AL, Weintrub PS, Cabana MD. Antibiotic Selection for Purulent Skin and Soft-Tissue Infections in Ambulatory Care: A Decision-Analytic Approach. Academic pediatrics. 2009;9(3):179-184. doi:10.1016/j.acap.2009.02.002.
10. Cadena J, Nair S, Henao-Martinez AF, Jorgensen JH, Patterson JE, Sreeramoju PV. Dose of Trimethoprim-Sulfamethoxazole to Treat Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2011;55(12):5430-5432. doi:10.1128/AAC.00706-11.